Review of In-patient PrescriptionNCT05894278
A Prescription Audit of Inpatient Department of Super Speciality Hospital in National Capital Region of India
An observational study of Review of In-patient Prescription, run by Kakatiya University at 1 site in India.
Trial summary
Prescription auditing is the art to check the detailing, compatibility and performance of the generated prescription from the physician to the pharmacist and patient, by means of the WHO checklist for prescription auditing. Read more about this study
- Who is it for?
- Ages 18 to 100 yearsHealthy volunteers can take part
- Conditions the study is for
- Review of In-patient Prescription
- What is being tested?
- Prescription data collection
- How many people
- 300 participants
- Where
- 1 siteIndia
- Study dates
- 1 Mar 2023to 28 May 2023
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 100 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Study population: Select the patient based on inclusion and exclusion criteria Collect the information from IP prescription and drug chart Identify prescribing errors and medication error To study the management of good prescription
Who may be able to join
- Participants who are willing to participate
- Participants who are admitted in the in-patient department
- Participants admitted during the study period
- Participants who have a prescription which is legible and complete
Who cannot join
- Participants who are unwilling to provide the required information
- Participants who are not admitted the in-patient department
- Participants whose prescription is not legible and competent
Trial locations and contacts
1 site in 1 country.
About this study
Official title: A Prescription Audit of Inpatient Department of National Accreditation Board for Hospitals and Healthcare Providers Approved Super Speciality Hospital in National Capital Region of India
Prescription auditing is the art to check the detailing, compatibility and performance of the generated prescription from the physician to the pharmacist and patient, by means of the WHO checklist for prescription auditing. An audit is defined as the review and evaluation of the healthcare procedures and documentation to compare the quality of care provided, with accepted standards.
In this study, we will collect In-patient prescriptions from Fortis Hospital. And it will be evaluated for 13 list out parameters i.e Hospital unique ID, patient name, age, sex, weight, date of consultation, cleanliness and legibility, brief history, allergies, clinical examination, presumptive or definite diagnosis, medicine prescribed by generic name, dose, duration, history of a previous adverse event, appropriate abbreviations used, drug-drug interaction, drug duplication, doctor name, registration number and signature. The study is analyzed by Statistical Process Control (SPC).
Read the detailed description
Aim of the study:
The aim of the study is to evaluate the quality of the prescription provided to the inpatient.
Objectives of the study:
To study the quality of good prescription In minimization of prescription errors and medication errors Also to comply with good clinical practice Enhancement of patient safety In the maintenance of rational prescribing To study the quality of care provided by the hospital to the patient
Plan of study:
To select the patient based on inclusion and exclusion criteria To collect the information from IP prescription and drug chart To identify prescribing errors and medication error To study the management of good prescription
Methodology:
Study Sites: Fortis Hospital, Noida, Uttar Pradesh (INDIA) Study Design: Observational cohort study Study Duration: 2 months (March, 2023 and May, 2023)
Study Sites: Fortis Hospital, Noida, Uttar Pradesh (INDIA) Study Design: Observational cohort study Study Duration: 2 months (March, 2023 and May, 2023)
Subject Eligibility:
- Inclusion Criteria Participants who are willing to participate Participants who are admitted in the in-patient department Participants admitted during the study period Participants who have a prescription which is legible and complete
- Exclusion Criteria Participants who are unwilling to provide the required information Participants who are not admitted the in-patient department Participants whose prescription is not legible and competent
- Source of the data: Review of In-patient prescription
Sample Size:
300 prescriptions
- Conditions
- Review of In-patient Prescription
- Being tested
- Prescription data collection
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Prescription data collectionOther
Prescription data collection
| Study group | Role | What they receive |
|---|---|---|
| Compliance | Prescription properly filled for specific parameters Receives: Other: Prescription data collection | |
| Non Compliance | Prescription is not filled with specific parameters Receives: Other: Prescription data collection | |
| Not available - NA | Prescription does not contain specific data Receives: Other: Prescription data collection |
What is being measured
The primary outcome is the main question the study is designed to answer.
Percentage prescription
Prescription filled for specific parameter
Measured: March 2023 and May 2023
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted8 Jun 2023
- Study start1 Mar 2023
- Primary completion28 May 2023
- Study completion28 May 2023
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Review of In-patient PrescriptionStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 300 participants (actual)
Sponsor and investigators
- Lead sponsor
- Kakatiya University
- Sponsor type
- University, hospital or other
- Collaborators
- Fortis Hospital, India
- Responsible party
- Principal investigator, Satyam Suman, Kakatiya University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05894278
- Sponsor's protocol ID
- FORTIS/IEC/2023/MAR/PA02
- Status last verified
- Jun 2023
- First submitted
- 28 May 2023
- Last updated
- 8 Jun 2023
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 8 Jun 2023. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- A Prescription Audit of Inpatient Department of National Accreditation Board for Hospitals and Healthcare Providers Approved Super Speciality Hospital in National Capital Region of India
- ClinicalTrials.gov ID
- NCT05894278
- Acronym / sponsor ID
- FORTIS/IEC/2023/MAR/PA02
- Conditions
- Review of In-patient Prescription
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 300 participants (actual)
- Lead sponsor
- Kakatiya UniversityUniversity, hospital or other
- Collaborators
- Fortis Hospital, India
- Study start
- 1 Mar 2023 (actual)
- Primary completion
- 28 May 2023 (actual)
- Study completion
- 28 May 2023 (actual)
- First posted
- 8 Jun 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Prescription auditing is the art to check the detailing, compatibility and performance of the generated prescription from the physician to the pharmacist and patient, by means of the WHO checklist for prescription auditing. An audit is defined as the review and evaluation of the healthcare procedures and documentation to compare the quality of care provided, with accepted standards.
In this study, we will collect In-patient prescriptions from Fortis Hospital. And it will be evaluated for 13 list out parameters i.e Hospital unique ID, patient name, age, sex, weight, date of consultation, cleanliness and legibility, brief history, allergies, clinical examination, presumptive or definite diagnosis, medicine prescribed by generic name, dose, duration, history of a previous adverse event, appropriate abbreviations used, drug-drug interaction, drug duplication, doctor name, registration number and signature. The study is analyzed by Statistical Process Control (SPC).
Detailed description
Aim of the study:
The aim of the study is to evaluate the quality of the prescription provided to the inpatient.
Objectives of the study:
To study the quality of good prescription In minimization of prescription errors and medication errors Also to comply with good clinical practice Enhancement of patient safety In the maintenance of rational prescribing To study the quality of care provided by the hospital to the patient
Plan of study:
To select the patient based on inclusion and exclusion criteria To collect the information from IP prescription and drug chart To identify prescribing errors and medication error To study the management of good prescription
Methodology:
Study Sites: Fortis Hospital, Noida, Uttar Pradesh (INDIA) Study Design: Observational cohort study Study Duration: 2 months (March, 2023 and May, 2023)
Study Sites: Fortis Hospital, Noida, Uttar Pradesh (INDIA) Study Design: Observational cohort study Study Duration: 2 months (March, 2023 and May, 2023)
Subject Eligibility:
- Inclusion Criteria Participants who are willing to participate Participants who are admitted in the in-patient department Participants admitted during the study period Participants who have a prescription which is legible and complete
- Exclusion Criteria Participants who are unwilling to provide the required information Participants who are not admitted the in-patient department Participants whose prescription is not legible and competent
- Source of the data: Review of In-patient prescription
Sample Size:
300 prescriptions
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Number of arms
- 3
| Arm | Type | Receives |
|---|---|---|
| Compliance | – | Other: Prescription data collectionPrescription properly filled for specific parameters |
| Non Compliance | – | Other: Prescription data collectionPrescription is not filled with specific parameters |
| Not available - NA | – | Other: Prescription data collectionPrescription does not contain specific data |
Who may qualify
- Ages
- 18 to 100 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
- Study population
- Select the patient based on inclusion and exclusion criteria Collect the information from IP prescription and drug chart Identify prescribing errors and medication error To study the management of good prescription
Key inclusion criteria (4 listed)
- Participants who are willing to participate
- Participants who are admitted in the in-patient department
- Participants admitted during the study period
- Participants who have a prescription which is legible and complete
Key exclusion criteria (3 listed)
- Participants who are unwilling to provide the required information
- Participants who are not admitted the in-patient department
- Participants whose prescription is not legible and competent
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Prescription data collectionPrescription data collection | Other | Compliance, Non Compliance, Not available - NA |
Primary outcome
Percentage prescription
Time frame: March 2023 and May 2023
Prescription filled for specific parameter
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 8 Jun 2023.
- Individual participant dataSharing planned: No
Related trials for Review of In-patient Prescription
Recruiting
Improved Prescribing for Older Nursing Home Patients
Nursing Home Residents, Older People
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Review of In-patient Prescription, run by Kakatiya University at 1 site in India.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 8 Jun 2023. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in India. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Percentage prescription (time frame: March 2023 and May 2023). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Jun 2023.